References
- Tan GHC, Shannon NB, Chia CS, et al. Platinum agents and mitomycin C-specific complications in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Int Journal of Hyperthermia. 2017;1–6. doi:10.1080/02656736.2017.1345014
- Passcot G, Bakrin N, Isaac S, et al. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Eur J Surg Oncol. 2014;40:957–962.
- Esquivel J, Averbach A, Chua TC. Laparoscopic cytoreductive suirgery and hyperthermic intraperitoneal chemotherapy in patients with limited peritoneal surface malignancies: feasibility, morbidity, and outcome in an early experience. Ann Surg. 2011;253:764–768.